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AN ANIMAL MODEL OF ALZHEIMER'S DISEASE I : BEHAVIORAL AND 
HISTOLOGICAL ASSESSMENT FOLLOWING INTRAHIPPOCAMPAL 
INJECTIONS OF A B-AMYLOID 25-35 IN THE RAT 
David Kang, Dept of Psychology, IWU, Dr. Wayne A. Dornan* 
Perhaps no other pathology has caused more interest in the 
neuroscientific community in recent years than Alzheimer'S disease (AD). 
Alzheimer's disease is a neurodegenerative disease and the major cause of 
dementia in North America. Moreover, it is presently the 4th major cause of 
death in the U.S. The total annual cost to the nation for the care of AD 
patients is estimated at 90 billion, including medical and nursing home care, 
social services, and early death. More importantly, for victims and their 
loved one, the dementias are devastating. Thus AD represents a formidable 
challenge for the research community. While the mechanism of neuronal 
atrophy in AD is unknown, pathologically AD is characterized by extracellular 
deposition of neuritic plaques (NP) and a generation of neurofibrillary tangles 
typically found in the cerebral cortex, hippocampus and basal forebrain. 
Accumulating evidence suggests that the major constituent of NP, a beta­
amyloid protein composed of 39-42 amino acids, possesses neurotoxic 
properties. Presently, nothing is known regarding the effects of intracerebral 
injections of beta-amyloid on memory. In this study the effects of a variety of 
doses of beta-amyloid on spatial memory were assessed following bilateral 
injections into the hippocampus. Memory deficits (working and reference) 
were assessed in a 8-arm radial arm maze. Preliminary results indicate that 
there is a clear disruption of learning in the experimental animals.  These 
results, along with a preliminary analysis of the cytoarchitecture of 
hippocampal and basal forebrain neurons will be presented. 
